Patients with colon cancer who still have cancer cells in their blood after surgery may improve their survival odds with ...

Frequent colorectal polyp diagnoses in first- and second-degree relatives are associated with an increased risk for colorectal cancer (CRC), especially early-onset CRC. Researchers evaluated the ...

SANG W. LEE PROCTOLOGY Clinical Professor; Chief, Colon and Rectal Surgery Keck Medicine of USC Dr. Sang Lee is one of the nation’s leading experts in ...

A randomized study has produced some hopeful news for colorectal cancer survivors with an unlikely suspect: the commonly used ...

*Number of genomic copies/μL. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This abstract does not include a full text component.

Phase Ib study of gevokizumab (GEVO) in combination with standard-of-care (SoC) anticancer therapies in patients (pts) with metastatic colorectal cancer (mCRC), metastatic gastroesophageal cancer ...

This investigation was initiated to determine whether NAFLD has a relationship to colorectal adenomatous polyps. Results: The prevalence of NAFLD was 41.5% in the adenomatous polyp group and 30.2% ...

Aspirin use in patients with PI3K-mutated colorectal cancer helped to reduce disease recurrence, highlighting the importance ...

The unadjusted caecal intubation rate (CIR) was 92.3%. When adjusted for impassable strictures and poor bowel preparation the CIR was 95.8%. The polyp detection rate was 32.1%. The polyp detection ...

Three-year results from the ALASCCA trial (NCT02647099), presented at the 2025 ASCO Gastrointestinal Cancer Symposium, showed ...